Sign In
Buy FLGT
$18.14
-0.560 (-2.99%)
At Close: Jun 03, 2026
Jim Cramer does his homework on Fulgent Genetics
08:06pm, Wednesday, 16'th Nov 2022
Cramer circled back to Fulgent Genetics after an investor asked him about the stock last week.
Fulgent Genetics, Inc. (FLGT) Q3 2022 Earnings Call Transcript
08:41pm, Monday, 07'th Nov 2022
Fulgent Genetics, Inc. (NASDAQ:FLGT ) Q3 2022 Results Conference Call November 7, 2022 4:30 PM ET Company Participants Melanie Solomon - IR Ming Hsieh - CEO Paul Kim - CFO Brandon Perthuis - Chief Com
Fulgent Genetics, Inc. (FLGT) Beats Q3 Earnings and Revenue Estimates
07:35pm, Monday, 07'th Nov 2022
Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of 88.24% and 1.89%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the sto
After 3rd-Quarter Carnage, Look at the Casualty List
11:05am, Monday, 03'rd Oct 2022
Investors suffered their third unpleasant quarter in a row in the quarter that just ended. After this pounding, quite a few stocks look attractive to me.
Why I Bought More of This Under-the-Radar Stock
06:30am, Friday, 05'th Aug 2022
This healthcare business has tailwinds behind it.
Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q2 2022 Results - Earnings Call Transcript
11:02pm, Thursday, 04'th Aug 2022
Fulgent Genetics, Inc. (NASDAQ:FLGT ) Q2 2022 Results Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Nicole Borsje - Investor Relations, The Blueshirt Group Ming Hsieh - Chair
Fulgent Genetics, Inc. (FLGT) Q2 Earnings and Revenues Beat Estimates
09:03pm, Thursday, 04'th Aug 2022
Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of 6.85% and 2.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
2 No-Brainer Stocks to Buy Right Now for Less than $55
11:30am, Tuesday, 17'th May 2022
These companies have low share prices and high potential.
Fulgent Is Putting Its Cash Bonanza To Work
05:35pm, Sunday, 15'th May 2022
The company has raked in well over $1B of cash from its epic Covid testing ramp up, apart from a host of contacts and putting the company on the map. It is spending some of that on acquisitions and a
Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q1 2022 Results - Earnings Call Transcript
07:58pm, Tuesday, 03'rd May 2022
Fulgent Genetics, Inc. (NASDAQ:FLGT ) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Nicole Borsje - IR Ming Hsieh - CEO Brandon Perthuis - Chief Commercial Officer Larry
Fulgent Genetics, Inc. (FLGT) Surpasses Q1 Earnings and Revenue Estimates
06:49pm, Tuesday, 03'rd May 2022
Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of 14.12% and 6.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
This Stock Grew 135% Last Year and Is Down 50% From Its Highs
02:15pm, Thursday, 28'th Apr 2022 The Motley Fool
Is Fulgent an underrated stock or a value trap?
This Stock Grew 135% Last Year and Is Down 50% From Its Highs
10:15am, Thursday, 28'th Apr 2022
Is Fulgent an underrated stock or a value trap?
Analysts Estimate Fullgent Genetics (FLGT) to Report a Decline in Earnings: What to Look Out for
07:01pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Fullgent Genetics (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fulgent Genetics (FLGT) to Post Q1 Earnings: What's in Store?
12:38pm, Monday, 25'th Apr 2022 Zacks Investment Research
Strategic investments and expanding operations in China are likely to have contributed to Fulgent Genetics' (FLGT) first-quarter performance.
